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For the fluorescence imaging of biologically active small compounds, the development of
compact fluorophores that do not perturb bioactivity is required. Here we report a compact
derivative of fluorescent 1,3a,6a-triazapentalenes, 2-isobutenylcarbonyl-1,3a,6a-triazapenta-
lene (TAP-VK1), as a fluorescent labeling reagent. The reaction of TAP-VK1 with various
aliphatic thiols proceeds smoothly to afford the corresponding 1,4-adducts in high yields, and
nucleophiles other than thiols do not react. After the addition of thiol groups in dichlor-
omethane, the emission maximum of TAP-VK1 shifts to a shorter wavelength and the
fluorescence intensity is substantially increased. The utility of TAP-VK1 as a compact
fluorescent labeling reagent is clearly demonstrated by the labeling of Captopril, which is a
small molecular drug for hypertension. The successful imaging of Captopril, one of the most
compact drugs, in this study demonstrates the usefulness of compact fluorophores for
mechanistic studies.
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F luorescent organic molecules are an important class ofcompounds in modern science and technology, and they arewidely used in biological imaging probes, sensors, lasers, and
light-emitting devices1–3. The development of useful fluorescent
organic molecules is thus crucial for the advancement of many
industries, and has been a subject of intensive research4–6. The
field of chemical biology in particular has recently seen rapid
advances due to the development of useful fluorescent probes, and
various biological phenomena have thereby been elucidated7–11.
The introduction of organic fluorophores into biologically active
molecules such as drugs, natural products, hormones, peptides,
and proteins has been one of the most useful ways to study these
molecules mechanistically by visualizing their localization and
behavior inside cells and tissues12–14. However, a key improve-
ment is still needed for commonly used fluorescent organic
molecules. Most highly fluorescent molecules are large in relation
to bioactive organic compounds, and fluorescence-labeled com-
pounds sometimes lose their biological activities as a result of the
structural modifications. Even proteins that interact with large
biomolecules can lose their interaction affinities when fluorescent
molecules are introduced near the binding site. Thus, the devel-
opment of compact fluorescent labeling reagent has still been
strongly demanded (Fig. 1).
Herein, we report the successful development of a compact
fluorescent labeling reagent that specifically reacts with aliphatic
thiols based on the 1,3a,6a-triazapentalene (TAP) skeleton, in
which the usefulness of the compact fluorophore is clearly
demonstrated by the fluorescence imaging of small-molecule drug
in living cells.
Results
Development of a most compact derivative of 1,3a,6a-triaza-
pentalene. We recently discovered that a 1,3a,6a-triazapentalene
(TAP) (1) skeleton is a compact and highly fluorescent chro-
mophore with the potential to overcome the molecular size
problem (Fig. 2)15, and it has been applied to various fluorescent
probes16–19. Interestingly, the fluorescence of the TAPs shifted to
longer wavelengths along with the inductive effect of the 2-
substituents15,19–24. By exploiting this effect, we recently devel-
oped yellow and red fluorescent 1,3a,6a-triazapentalene deriva-
tives that are relatively smaller than the conventional yellow and
red fluorescent molecules, as shown in Fig. 225. However, these
derivatives might be made still more compact: the phenyl group
at the C2-position could be removed to reduce their overall
molecular size. We thus develop a most compact fluorescent
labeling reagent without 2-phenyl group. First, we investigated
the effective functional groups at the 2-position as well as the
phenyl group, and we found that the ketone group was the most
stable against photoirradiation (Supplementary Note 1 and Sup-
plementary Table 1). To develop the ketone analog as a compact
fluorescent labeling reagent, we designed the vinyl ketone 2 as
shown in Fig. 2. The vinyl ketone moiety of 2 was expected to



















Fig. 1 Desirable fluorescent labeling group for intracellular tracking of biologically active compounds. Since the large molecular size of fluorescent
groups can diminish the biological activity of the parent small compound, the smallest possible molecular size is demanded. On the other hand, intracellular
reacting probes have problems with nonspecific labeling and low labeling rates. X = no good, O = good and Triangle = moderate.
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active compounds by a typical 1,4-addition reaction. In addition,
the fluorescence color and intensity of 2 might be dramatically
changed by the addition of a thiol group due to the change of
electron state from conjugation to deconjugation. Thus, we
started the synthesis of vinyl ketone derivatives of TAP.
Synthesis of vinyl ketone analog of TAP. The synthesis of vinyl
ketone analog 2 was started with 2-methoxycarbonyl-1,3a,6a-tria-
zapentalene 4, which was readily obtained by the previously reported
click-cyclization-aromatization cascade reaction15. The hydrolysis of
4 followed by condensation with N,O-dimethylhydroxylamine
afforded Weinreb amide 5 in an 87% two-step yield. However, the
treatment of 5 with vinylmagnesium bromide gave not vinyl ketone
2 but amine 6a derived from a 1,4-addition reaction of the hydro-
xylamine with the resulting vinyl ketone. Although various condi-
tions were examined, including different conditions in the work-up,
the desired vinyl ketone 2 was not obtained due to the high reactivity
of vinyl ketone. Similarly, the use of 1-propenyl magnesium bromide
as a nucleophile afforded amine 6b, and no vinyl ketone analogs
were detected. In contrast, nucleophilic addition of isobutenyl
magnesium bromide resulted in the desired vinyl ketone 2a in good
yield, because the dimethyl group at the β-position of 2a was bulky
enough to disturb the 1,4-addition of hydroxylamine and other
nucleophiles. Thus, the 1,3a,6a-triazapentalene analog directly con-
nected with vinyl ketone at the 2-position was obtained first, and we
named 2a “TAP-VK1” (Fig. 3).
Reaction of TAP-VK1 with thiols. Having prepared vinyl ketone
2a (TAP-VK1), we next investigated the reactivity with thiols.
Despite the bulky dimethyl group at the β-position, 2a reacted
smoothly with ethanethiol 7a. After optimization of the reaction
conditions, we found that treatment of thiol 7a with 1.2 equiv. of
2a as a fluorescent labeling reagent in the presence of 1.0 equiv. of
tetramethylguanidine (TMG) in dichloromethane (0.2 M) affor-
ded the desired 1,4-adduct 3a in 95% isolated yield. The reaction
using 5 mol% of TMG also proceeded smoothly without a sig-
nificant loss of yield, and 3a was obtained in 87% yield (Fig. 4a).
Interestingly, as we expected, the fluorescence properties of 2a
were dramatically changed after the addition of ethanethiol (7a).
The 1,4-adduct 3a showed a noteworthy shorter-wavelength shift
of the fluorescence maximum from the 574 nm of 2a to 521 nm,
along with a change of florescence color from yellow to green. In
addition, the fluorescence quantum yield (ΦF) was substantially
increased up to 10 times (Fig. 4a)26–29. Therefore, we also
investigated the time course of fluorescence in the reaction of 2a
with 7a (Fig. 4b). The fluorescence color of the reaction mixture
was changed to green within only 5 min of starting, and the
fluorescence intensity subsequently increased with the time
course and reached a maximum at 50 min (Fig. 4b). Therefore,
TAP-VK1 (2a) was proven to be a useful compact thiol-labeling
reagent that shows good reactivity and an increase of fluorescence
after labeling, in which the background fluorescence of the
unreacted 2a would not affect the fluorescence observation. In
addition, both 2a and the thiol adduct 3a also showed large
positive fluorescence solvatochromism (Supplementary Table 2),
as is the case with previously reported derivatives of 1,3a,6a-
triazapentalenes. In clear contrast, other nucleophiles such as
ethylamine, ethanol, and ammonium acetate did not react with 2a
at all under various conditions30. TAP-VK1 (2a) thus has great
potential as a thiol specific fluorescent labeling reagent that does
not need purification after labeling. The quantum chemical cal-
culation using TD-DFT method revealed that the shift of emis-
sion maximum attributed to the decreased charge-transfer
character in 3a, where the electronic conjugation of the 2-
substituents is terminated in 3a. (For detail information, see
Supplementary Note 2 and Supplementary Fig. 1).
Reaction of 2a with various thiols in dichloromethane. Having
established the optimum conditions for the thiol-labeling in organic
solvent, we next examined the reactions with various thiols (Fig. 5).
The reactions of aliphatic thiols such as 1-dodecanethiol 7b, allyl-
thiol 7c, and benzylthiol 7d proceeded smoothly to give the desired
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Fig. 2 Structure and fluorescence properties of 1,3a,6a-triazapentalene
and the expansion to the most compact fluorescent labeling reagent.
a Previous work; structure of 1,3a,6a-triazapentalene (TAP) and the
fluorescence properties of TAP that change according to the inductive
effect at the C2-position. b This work; the ketone group was observed to be
a more photostable functional group than alkyl, amide, or ester. To use the
ketone group as a compact fluorescent labeling reagent, the application of a
vinyl ketone group was planned with a view to the labeling of the thiol
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    EDCI, DMF
2 steps, 87%
Fig. 3 Synthesis of TAP-VK1 (2a). 2-Methoxycarbonyl-1,3a,6a-
triazapentalene 4 was successfully converted into vinyl ketone 2a by sequential
reactions consisting of hydrolysis, a condensation with the Weinreb amine, and
a nucleophilic addition of isobutenyl magnesium bromide.
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thiol groups of 1,3-propanedithiol 7e were also readily reacted with
2.2 equiv. of 2a; i.e., the 1,4-additions of thiol to 2a occurred twice,
and the bis-TAP adduct was obtained in 86% yield. Interestingly,
thiols possessing other nucleophilic functional groups, such as
alcohol 7f, amine 7g, and triazole 7h, specifically reacted with only
thiols in excellent yield, and no byproducts derived from the
addition of other nucleophiles were observed. Since the amino
group of 7g served as a base, we conducted the reaction of 7g,
which has poor solubility in dichloromethane, without TMG in
water. Although the 1,4-adduct from 7g formed a seven-membered
cyclic imine (see Supplementary data), the intermolecular con-
densation reaction of amines with ketone moieties of 2a and/or 1,4-
adducts did not occur at all under various conditions. The 1,4-
addition reactions of the secondary thiol 7i, protected amino acid
7j, and protected dipeptide 7k also proceeded smoothly to afford
labeled products in 82%, quantitative, and 91% yields, respectively.
All of the 1,4-adducts clearly showed a noteworthy shorter wave-
length shift of the emission maximum and the substantial increase
of the fluorescence intensity compared to those of 2a. Therefore,
TAP-VK1 (2a) was demonstrated to be applicable to various ali-
phatic thiols with fluorescence turn-on. It is also noteworthy that
only 1.2 equiv. of TAP-VK1 is enough for the labeling of thiol. In
contrast, several aromatic thiols did not react with 2a (Supple-
mentary Table 3).
Reaction of 2a with peptides and protein in water. Since the
reaction of TAP-VK1 (2a) with 7g proceeded smoothly in water,
we suspected that 2a has potential for use in the labeling of
various biologically active compounds in water (Fig. 6). We
therefore attempted to directly label a free glutathione 7l in a
water solution, and the reaction of 7l with 2.0 equiv. of 2a in
sodium phosphate buffer solution (pH 7.0) at room temperature
was found to proceed smoothly. We directly subjected the crude
3l to reverse-phase silica gel column chromatography to give pure
3l in 47% yield. Although the 1H NMR of the crude 3l suggested
that the reaction proceeded quantitatively, the isolated yield of 3l
was decreased due to the adsorption of 3l on silica gel. Thus, we
found that 0.1 M sodium phosphate buffer solution (pH 7.0)
without additives was the best reaction condition for the labeling
of free peptides and protein (vide infra). We next attempted to
label a more complicated peptide to further assess the labeling
potential of TAP-VK1 (2a) (Fig. 6). We synthesized octapeptide
7m as a challenging substrate that possesses many reactive
functional groups, including guanidine, alcohol, imidazole,
amine, and phenol. When the octapeptide 7m was incubated with
20 equiv. of 2a in 0.1 M sodium phosphate buffer (pH 7.0) for 6 h,
the cysteine residue of 7m was clearly reacted to give labeled
peptide 3m in quantitative yield. The high-performance liquid
chromatography (HPLC) analysis of the above reaction mixture
clearly showed that there were no peaks other than the labeled
product (3m) and excess labeling reagent (2a); i.e., no byproducts
that reacted at other residues and no degradation products of 2a
were observed (Supplementary Fig. 2). It was thus demonstrated
that 2a specifically reacted only with a thiol group and did not
react with other functional groups at all, even when a large excess
amount of 2a was used. In addition, the labeling reaction using
TAP-VK1 (2a) was extended to bioconjugation with human
serum albumin (HSA), which possesses only one free cysteine
residue31, and the HSA was cleanly labeled by 2a (Supplementary
Fig. 3). TAP-VK1 as a fluorescent labeling reagent was thus
confirmed to be also applicable to proteins.
Model imaging of TAP-VK1. Our experiments revealed that
TAP-VK1 (2a) is applicable to directly label peptides and protein in
water. However, the above compounds 3l and 3m labeled by TAP-
VK1 (2a) did not exhibit fluorescence in water, which was distinct
from the case with organic solvent. In addition, 2a itself does not
emit any light in water. In contrast, the absorption intensity and the
molar absorption coefficient (ε) of the labeled compounds (3l, 3m)
and 2a in water were similar to or higher than those in dichlor-
omethane. We therefore expected that these labeled compounds
would also generate fluorescence under hydrophobic conditions;
i.e., the labeled compounds would become luminescent when
delivered to a hydrophobic area. If so, 2a might suppress the
background fluorescence from the culture medium. To investigate
the fluorescence switching of 2a between hydrophobic and hydro-
philic areas, we next attempted to deliver a water-soluble compound
labeled by 2a into cells. We prepared a water-soluble peptide 7n,
including a membrane-permeable R8 peptide as a model of a
bioactive compound, and we incubated it with 2.0 equiv of 2a in 1
mM sodium phosphate buffer at room temperature (Fig. 7). After 3
h, an HPLC analysis showed that 71% of 7n was converted into 3n
(see experimental details section in supplementary information),
and we diluted the reaction mixture with Dulbecco's Modified Eagle
Medium-fetal bovine serum (DMEM-FBS) (−). The resulting
mixture of 3n was directly treated with A549 cells and monitored
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Fig. 4 Reaction of 2a with ethanethiol (7a) and the time course of
fluorescence in the reaction. a TAP-VK1 (2a) smoothly reacted with
ethanethiol (7a) to afford the more highly fluorescent 3a in good yield, and 2a
did not react with amine and alcohol. b The fluorescence color of the reaction in
dichloromethane changed to green from yellow after 5min, and the
fluorescence intensity increased with the time course and reached a maximum
at 50min (exited at 370 nm in CH2Cl2). TMG, 1,1,3,3-tetramethylguanidine.
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nm, respectively (Fig. 7). As we expected, 3n, which does not show
fluorescence in water, became luminescent within A549 cells.
Treatment with a 10 μM mixture of 3n visualized living A549 cells
under fluorescence microscopy without washing of the medium
culture (Fig. 7a), and the fluorescence of 3n inside cells was further
clearly observed when a 25 μM mixture was used (Fig. 7b). In clear
contrast, the interiors of the control cells that were treated with a 10
μM solution and a 25 μM solution of peptide 7n in DMEM FBS (−)
and 10 μM and 25 μM solutions of TAP-VK1 (2a) in DMEM FBS
(−) containing 0.1% DMSO were not stained (Fig. 7c–f). The
fluorescence intensities of 3n inside the cells exhibited concentra-
tion-dependence, whereas treatments with a solution of TAP-VK1
did not result in concentration-dependence (Supplementary Fig. 4).
These experiments clearly indicated that the labeled peptide 3n was
incorporated through macropinocytosis of the R8 peptide32,33, and
the fluorescence of 3n became to emit after being carried into the
cells. We considered that 3n was encapsulated by the membrane of
intracellular vesicles as the common mechanism of macro-
pinocytosis so that 3n, partially localized in the hydrophobic
membrane region, recovered fluorescence. The vesicles were deliv-
ered to organelles, exhibiting fluorescence in the cytoplasm. The
advantage of TAP-VK1 was that the reaction mixture of thiol-
labeling could be directly used for functional analyses without the
isolation and purification of the labeled substrate, because the
reaction in sodium phosphate buffer (pH 7.0) did not require any
reagents other than 2a, and excess 2a did not disturb the fluores-
cence observation and did not show cytotoxicity, unlike other
compact fluorescent labeling reagents. Actually, when excess
amount of coumarin-maleimide (8), 4-Chloro-7-nitro-benzofur-
azan (NBD-Cl) (9), and 4-Fluoro-7-sulfamoylbenzofurazan (ABD-
F) (10) as the commonly used fluorescent labeling reagents for
thiols were directly treated with vascular endothelial cells (MBEC 4)
as a model cells (vide infra), these fluorophores adsorbed on the cell
surface and also induced the cell damage (Supplementary Fig. 5).
Therefore, the contamination of excess amount of these labeling
reagents obviously disturbs the fluorescence observation of living
cells, so purification and isolation of labeled substrates should be
required. While, TAP-VK1 (2a) did not affect the cells and the
fluorescence observation (Supplementary Fig. 5) so that the direct
treatment of the labeling reaction mixture is possible. On the other
hand, treatment with a 50 μM solution of 3n caused cell damage
due to the toxicity derived from R8 peptide (Supplementary Fig. 6).
Drug imaging with TAP-VK1. Having confirmed the fluores-
cence of TAP-VK1 (2a) in the cells, we finally attempted to image
small-molecule drug using 2a. We adopted captopril (7o) as a small
biologically active compound possessing thiol group. Captopril is a
drug that inhibits angiotensin converting enzyme (ACE) and
has been used for treatment of hypertensive patients34. Although
the measurement of the captopril (7o) content in biological
sample such as cells, tissues, urine and so on has been intensively
studied35–37, there is to our knowledge no report of the fluorescence
imaging of 7o inside cells. The main reason is probably that the
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Fig. 5 The reaction of 2a with various thiols. Various thiols were smoothly labeled by 2a in good yields, and all 1,4-adducts showed a noteworthy shorter
wavelength shift of the emission maximum and a substantial increase of the fluorescence intensity. The isolated yield, the fluorescence maximum
wavelength and the fluorescence quantum yield of 1,4-adducts are shown. Dithiol 7e was treated with 2.2 equiv of 2a, and the reaction with 7g was
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7m
Conversion yield > 99%
2a (2.0 equiv)
47% (isolated)
Fig. 6 Reactions of 2a with peptides in aqueous solution. The thiol groups
of cysteine were smoothly labeled by 2a in aqueous solution.
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inhibitory activity due to the compact molecular size of captopril.
Furthermore, since the probes that intracellularly react with thiols
also have problems with nonspecific labeling and low labeling rate,
accurate visualization of 7o is difficult. Thus, fluorescent labeling of
7o without loss of inhibitory activity is the most proper approach
for the imaging of 7o inside cells, and compact fluorescence labeling
reagent is significant to this end. First, we examined the labeling of
7o with TAP-VK1 and its ACE inhibitory activity. Treatment of 7o
with 1.5 equiv. of 2a and 1.1 equiv. of TMG in dichloromethane
afforded labeled captopril (3o) in 82% yield as a 4:1 diastereomeric
mixture at the methyl group (Fig. 8). Since the epimer of 7o is
known to be inactive34,38, the diastereomeric mixture of 7o was
applied for the ACE activity assay using ACE-Kit WST (See the
“Methods” section). Surprisingly, TAP-VK1-labeled 3o retain the
potent inhibitory activity of captopril, whereas fluorescein-labeled
captopril dramatically lost the activity (Fig. 8). Thus, it was found
that the introduction of TAP-VK1 does not affect the activity even
for very small molecules such as 7o, and it clearly proved that TAP-
VK1 is powerful tool for the fluorescence labeling of small biolo-
gically active compound such as drugs, natural products, hormones,
peptides, and so on.
Having confirmed the ACE inhibitory activity of captopril (7o)
labeled by TAP-VK1, we finally attempted to visualize the
localization of captopril inside vascular endothelial cells. A 50 μM
solution of 3o in DMEM FBS (−) was treated with mouse brain-
derived vascular endothelial cells (MBEC4) at 37 °C, and the cells
were monitored by confocal laser microscope with excitation and
emission wavelengths of 405 and 490 nm, respectively, at
24 h after treatment (Fig. 9). As we expected, the observable
fluorescence appeared in immobilized cells after 24 h (Fig. 9a, b),
























Fig. 8 ACE activity assay of captopril and its fluorescent labeled
derivatives. a Labeling reaction of captopril (7o) with TAP-VK1 proceeded
smoothly to give 3o in good yield. b The introduction of TAP-VK1 did not
affect the potent ACE inhibitory activity even with small drugs like captopril,
whereas fluorescein labeling induced loss of the activity. We confirmed that
the regeneration of captopril by retro-thia-Michael reaction did not occur
because no peak of captopril was detected by the HPLC analysis of the
assay solution of 3o.
Fig. 9 Observation of captopril in vascular endothelial cells. Living cells
were cultured with 50 µM of 3o (a, b), left untreated (c), cultured with 50
μM of 7o and 50 µM of 2a containing 0.1% DMSO as controls (d, e), or
cultured with the mixture of 50 μM of 3o and 100 μM of 7o as a
competition experiment (f). The fluorescence of 3o inside the cells was
clearly visualized (a, b), whereas no fluorescence was observed inside of
the untreated cells (c). Inside of cells treated by captopril (d) and TAP-VK1
(e) showed very weak fluorescence, and their fluorescence intensities were
much lower than that of 3o. The presence of 2.0 equiv. of captopril
competed with 3o and substantially reduced the fluorescence of 3o (f). The
Cell nuclei were stained by PI (propidium iodide; red fluorescence) for
detailed fluorescence observation (b–f). The fluorescence of 3o was
observed in the cytoplasm. The uptake of 3o was monitored by confocal
microscopy (ZEISS LSM700; Carl Zeiss) in a fluorescence image with
excitation and emission wavelengths of 405 and 490 nm, respectively
(a–f). Scale bar= 20 µm.
2a (2.0 equiv)






Fig. 7 Observation of 3n in A549 cells. Living cells were cultured with
10 µM or 25 µM of 3n (a, b), cultured with 10 µM or 25 µM of 2a containing
0.1% DMSO as a control (c, d), left untreated (e), or cultured with 25 μM of
7n containing 0.1% DMSO (f). The fluorescence of 3n inside the cells was
clearly visualized (a, b), whereas that inside the cells treated by TAP-VK1
(c, d), the untreated cells (e) and the cells treated with R8 peptide (f) was
not visualized under several concentrations. Cell nuclei were stained by PI
(propidium iodide; red fluorescence) for detailed fluorescence observation,
and 3n was observed in the cytoplasm. The uptake of 3n was monitored by
confocal microscopy (ZEISS LSM700; Carl Zeiss) in a fluorescence image
with excitation and emission wavelengths of 405 and 490 nm, respectively
(a–f). Scale bar= 20 µm.
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(Fig. 9c). On the other hand, the interiors of the cells that were
treated with a 50 μM solution of captopril 7o in DMEM FBS (−)
and 50 μM solutions of TAP-VK1 (2a) in DMEM FBS (−) showed
weak fluorescence (Fig. 9d, e), however, the fluorescence intensities
were significantly lower than 3o (Supplementary Fig. 7). In
addition, competition experiments with TAP-VK1-labeled captopril
3o and unlabeled captopril 7o reduced the intracellular fluorescence
(Fig. 9f), suggesting that TAP-VK1-labeled captopril 3o accumu-
lated in ACE and resulted in fluorescence staining of ACE.
In addition, to evaluate the advantages of TAP-VK1 (2a) as the
novel compact fluorophore (5+ 5 membered ring), commonly
used small molecular fluorophores such as coumarin (8) (6+ 6
membered ring), NBD (9) (6+ 5 membered ring), and ABD (10)
(6+ 5 membered ring) were similarly introduced into the thiol
group of captopril to give captopril-coumarin (8o), captopril-
NBD (9o), and captopril-ABD (10o), respectively (Supplemen-
tary Table 4). Similar treatment of these labeled captoprils with
MBEC4 revealed that 2a was the most efficient fluorophore that
retained the original behavior of captopril (Supplementary Fig. 8).
The fluorescence of 9o and 10o were not observed inside the cells,
i.e., NBD and ABD probably disturbed the delivery of captopril
into cells. On the other hand, although 8o was incorporated into
the cells and emitted fluorescence inside cells, the fluorescence
intensity was much lower than that of Captopril-VK1 (3o), and
the distribution of 8o appeared to be more non-specifically
localized compared to that of 3o (Supplementary Fig. 8).
Finally, to confirm that 3o fluorescently stained ACE, a
comparative experiment with antibody staining was performed
(Fig. 10a–d). The fluorescence distribution of antibody staining
experiment of ACE in MBEC 4 cells was co-localized with the
fluorescence of TAP-VK1-labeled captopril 3o. The image of
antibody staining in Fig. 10 is similar to the previously reported
immunolocalization of ACE in CHO and HUVEC cells39,40, and
our imaging properly showed the behavior of ACE in cultured
vascular endothelial cells. Thus, by using TAP-VK1 (2a), we first
succeeded in the visualization of the captopril (7o) binding to the
target protein in vascular endothelial cells. It is noteworthy that
very small drug such as captopril can be fluorescently labeled
without loss of biological activity. On the other hand, the
coumarin analog 8o were partially distributed to ACE, but were
also localized in other area (Fig. 10e–h), while TAP-VK1 analog
3o mainly co-localized in ACE. Therefore, TAP-VK1 is
considered to be more effective fluorophore in tracking the
intracellular localization of the target compound. Furthermore, to
evaluate the photostability of 3o, the MBEC 4 cells treated with
3o and 8o were exposed to the continuous excitation laser at 405
nm (5 mW Diode Laser) and measured their fluorescence
intensity. The fluorescence half-life time (T1/2) of 3o (76.9 min)
was longer than that of 8o (41.5 min), and TAP-VK1 was found
to possess good photostability (Supplementary Fig. 9).
Discussion
Fluorescence imaging is one of the most powerful approach for
the mechanistic study of biologically active compound. However,
fluorescence imaging of biologically active small compounds in
cells and tissues is generally difficult because the introduction of
fluorescent labeling groups induces the change of biological
activities of parent small compound according to the molecular
Fig. 10 Observation of captopril derivatives (3o and 8o) in vascular endothelial cells. Living cells were cultured with 100 µM of 3o and 8o. The
fluorescence distribution of 3o was mainly consistent with that of ACE fluorescently stained with anti-ACE antibody (a–d), while the fluorescence
distribution of 8o showed incomplete consistent compared to 3o (e–h). The enlarged images inside white line show the difference more clearly (j–o).
The uptake of 3o and 8o were monitored by confocal microscopy (ZEISS LSM700; Carl Zeiss) in a fluorescence image with excitation and emission
wavelengths of 405 and 490 nm, respectively. Scale bar= 20 µm.
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size and/or physical properties of fluorescent labeling groups. To
solve this problem, we herein developed a compact and thiol-
specific fluorescent labeling reagent, TAP-VK1 (2a).
TAP-VK1 (2a) smoothly react with various aliphatic thiols in
organic and water solvent to give 1,4-adducts 3 in high yield, and
other nucleophiles such as alcohols, amines, and carboxylate did
not react with 2a at all. The validity of 2a as fluorescent labeling
group was confirmed by TAP-VK1-labeled R8 peptide that
permeates into cells and emit fluorescence inside cells. Indeed, the
utility of 2a as the compact labeling reagent was demonstrated by
the labeling of captopril, i.e., TAP-VK1-captopril retains potent
ACE inhibitory activity, and its fluorescence accumulated in ACE
in vascular endothelial cells.
TAP-VK1 (2a) has various advantages in addition to the
compact molecular size as follows: (i) high thiol specificity, (ii)
convenient reaction condition for labeling, (iii) high labeling yield
in both organic solvents and water, (iv) significant increase in
fluorescence intensity after labeling so that background fluores-
cence of unreacted 2a do not disturb fluorescence observation,
while the commonly used compact labeling reagents disturbed,
and (v) direct treatment of the labeling reaction mixture is pos-
sible. On the other hand, there are still some points to be
improved in 2a such as increase of intracellular fluorescence
intensity. To this end, tuning the 2a by introducing hydrophobic
substituents so as to emit fluorescence in water is required, we
will undertake this study in the future. Although improvement of
2a is still necessary, the first successful imaging of captopril, one
of the most compact drugs, in this study demonstrated the use-
fulness of compact fluorescent probes for mechanistic study.
Thus, development of compact molecular probes will be an
intensive research topic in the future.
Methods
Chemical synthesis. Detailed synthetic procedures and compound characteriza-
tion are described in the Supplementary Methods, and 1H and 13C NMR and
absorption and fluorescence emission spectra are also available (Supplementary
Figs. 14–57).
Human serum albumin for bioconjugation. Human serum albumin (Kenketsu
Albumin 20 “KAKETSUKEN”) was purchased from KAKETSUKEN (Kumamoto,
Japan). The albumin was defatted by treatment with charcoal as described in
literature41, dialyzed against deionized water, lyophilized, and stored at –20 °C until
used. To a solution of HSA (20.4 µM in 0.1 M sodium phosphate, pH 7.0, 98 µL)
was added TAP-VK1 (2a) (100 mM in DMF, 2 µL) and the mixture was incubated
at room temperature for 6 h. Then 5.0 µL aliquot was treated with 8.7 µL of sample
buffer (50 mM Tris-HCl, 2.0% (v/v) SDS, 6.0% (v/v) 2-mercaptoethanol, 10% (v/v)
glycerol and 0.050% (w/v) bromophenol blue in H2O) and heated at 100 °C
for 2 min.
Cell lines and culture. A549 cell line (obtained from RIKEN Cell Bank) and
MBEC4 cells42 were grown in Dulbecco’s Modified Eagle’s Medium (DMEM:
Sigma) containing 10% fetal bovine serum (FBS: Life Technologies), 70 mg/L
penicillin (Sigma) and 100 mg/L streptomycin (Sigma), and maintained in the same
culture medium at 37 °C in 5% CO2.
Confocal imaging. A549 cells or MBEC4 cells (5 × 104) were plated on 8well-
chamber slide (Nunc) and incubated with DMEM containing 10% FBS for a day.
The medium was replaced with serum-free DMEM containing compounds. The
cells were fixed with 4% paraformaldehyde (PFA) after incubation for 24 h at 4 °C.
Fixed cells were washed with phosphate based saline (PBS), and then stained with
2 µg/mL propidium iodide (Sigma) containing 20 µg/mL RNase A (Sigma) for 1 h
at room temperature. The specimens were viewed under a confocal fluorescent
microscopy (LSM700, Zeiss). After treatment of compounds, the MBEC4 cells were
fixed with 4% PFA for 24 h at 4 °C, and then immunostained by a two-step
incubation method. Fixed cells were treated at 4 °C overnight with the appro-
priately diluted anti-ACE antibody (Santa cruz). After washing with PBS con-
taining 0.05% Tween20, the cells were treated with Alexa Fluor 555-conjugated
anti-mouse IgG (Cell Signaling Technology). The specimens were viewed under a
confocal fluorescent microscopy.
Measurement of cellular fluorescence intensity. Digital imaging analysis was
also performed by a standard imaging software attached to the confocal micro-
scopic system in a fluorescence mode. The cells containing significant fluorescent
inclusions were designated as positive cells. Three different areas showing 20–30
cells each were viewed. The relative amount of the accumulated natural substrates
in microglial cell population was expressed as immunofluorescence intensity index
in each image (mean value). Relative fluorescence intensity was graded, ranging
from 0 to 255 in this system. The fluorescence intensity was linearly correlated with
the number of pixels showing a positive signal. Relative intensities for other cell
strains were calculated within the range of this gradation.
Computational details. The equilibrium geometry in the electronic ground (S0) is
determined by the density functional theory (DFT) calculations using the ωB97XD
functional43 with the 6-311+G(d,p) basis set, while the geometry optimization in
the singlet excited state (S1) is performed by the time-dependent DFT (TD-DFT)
calculations employing the same functional and basis set. In geometry optimiza-
tion, no symmetry constraint is imposed, and the solvent effects (dichloromethane)
are taken into account by the polarizable continuum solvation model (PCM). After
the geometry optimizations, the vertical excitation and emission energies are cal-
culated at the S0 and S1 equilibrium structures (denoted as (S0)min and (S1)min),
respectively. In calculating the excitation energies at (S0)min and (S1)min in
dichloromethane, the solvent effects are taken into account by the vertical exci-
tation/emission model (VEM)44 implemented in the VEMGAUSS package. All
DFT calculations are performed using the Gaussian09 program package45.
Angiotensin converting enzyme activity assay. The inhibition of ACE activity
according to captopril and its fluorescent labeled derivatives was performed using
Dojindo ACE Kit-WST test kit (Dojindo Laboratories, Kamimashiki-gun, Kuma-
moto. Briefly, the enzymatic reaction was initiated by the ACE and aminoacylase in
the mixture containing 3HB-GGG (3-hydroxybutyrate glycylglycylglycine) and the
ACE inhibitor. The mixture was then incubated at 37 °C for 60 min. During this
incubation, the substrate, 3HB-GGG, was enzymatically cut into 3HB-G and G-G
and then 3HB and G. The yield of 3HB was monitored indirectly through formazan
concentration, which was measured at 450 nm after 10 min at 25 °C. Absorbance
was measured at 450 nm using the microplate reader INFINITE F NANO Plus
(TECAN).
Measurement of absorbance/fluorescence spectra and fluorescence quantum
yields. Absorption spectra were recorded on a JASCO V-600 spectrometer and
corrected fluorescence spectra were recorded on a JASCO FP-8200 spectro-
fluorometer. Sample solutions were degassed thoroughly by purging with an Ar gas
stream for 30 min prior to the experiments and then sealed in their cells. All
measurements were carried out at 25 °C. Fluorescence quantum yields were esti-
mated by using 9,10-diphenylanthracene (9,10-DPA) in cyclohexane (ΦF= 0.91)
or rhodamine B in ethanol (ΦF= 0.94) as a standard. Values were calculated by
using the Eq. 1.
Φx ¼ Φst Astd=Ax½  Fx=Fstd½  n2x=n2std
  ð1Þ
std: standard, x: sample, A: absorbance at the excitation wavelength, F: fluorescence
spectrum area, n: refractive index
Data availability
The main data supporting the finding of this study are available within the paper and its
Supplementary Information file. Other relevant data are available from the
corresponding author upon reasonable request.
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